Molecular variants of the ATM gene in Hodgkin's disease in children

British Journal of Cancer

Volumn 90, Issue 2, 2004, Pages 522-525

  Liberzon, E ^a   Avigad, S ^a,b   Yaniv, I ^a,b   Stark, B ^b   Avrahami, G ^b   Goshen, Y ^b   Zaizov, R ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

ATM; Hodgkin lymphoma; Mutations

Indexed keywords

ADOLESCENT; ARTICLE; ATM GENE; CANCER PATIENT; CARCINOGENESIS; CENTROMERE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HETEROZYGOSITY; HODGKIN DISEASE; HUMAN; MALE; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADOLESCENT; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HODGKIN DISEASE; HUMANS; LEUCINE ZIPPERS; LOSS OF HETEROZYGOSITY; MALE; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 1342301545     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601522     Document Type: Article

References (36)

1. Broeks A, Urbanus JHM, Floore AN, Dahler EC, Klijn JGM, Rutgers EJTh, Devilee P, Russell NS, van Leeuwen FE, van't Veer LJ (2000) ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66: 494-500
2. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC, Croce CM (1999) ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59: 24-27
3. Buzin CH, Gatti RA, Nguyen VQ, Wen CY, Mitui M, Sanal O, Chen JS, Nozari G, Mengos A, Li X, Fujimura F, Sommer SS (2003) Comprehensive scanning of the ATM gene with DOVAM-S. Hum Mutat 21: 123-131
4. Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, Bosch F, Montserrat E, Cardesa A, Fernandez PL, Campo E (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 99: 238-244
5. Dohner H, Bloomfield CD, Frizzera G, Frestedt J, Arthur DC (1992) Recurring chromosome abnormalities in Hodgkin disease. Genes Chromosom Cancer 5: 392-398
6. Gronbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P (2002) ATM mutations are associared with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood 100: 1430-1437
7. Hasse U, Tigquely M, Leibundgut DE, Cajot J-F, Garvin AM, Tobler A, Borisch B, Fey MF (1999) Clonal loss of heterozygosity in microdissected Hodgkin and Reed-Sternberg cells. J Natl Cancer Inst 91: 1581-1583
8. Hecht F, Hecht BK (1990) Cancer in ataxia-telangiectasia patients. Cancer Genet Gytogenet 46: 9-19
9. Kukita Y, Tahira T, Sommer SS, Hayashi K (1997) SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 10: 400-407
10. Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin's disease. Cancer Res 26: 1063-1081
11. Morrell D, Cromartie E, Swift M (1986) Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst 77: 89-92
12. Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L (1999) Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. J Clin Oncol 17: 1259-1266
13. Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J (2002) Rare variants of ATM and risk for Hodgkin disease and radiation induced breast cancers. Clin Cancer Res 8: 3813-3819
14. Oguchi K, Takagi M, Tsuchida R, Taya Y, Ito E, Isoyama K, Ishii E, Zannini L, Della D, Mizutani S (2003) Missense mutation and defective function of ATM in a childhood acute patient with MLL gene rearrangement. Blood 101: 3622-3627
15. Ohsima K, Ishigiro M, Ohgami A, Sugihara M, Haraoka S, Suzumiya J, Kikuchi M (1999) Genetic analysis of sorted Hodgkin and Reed-Sternberg cells using comparative genomic hybridization. Int J Cancer 82: 250-255
16. Olsen JH, Hahnemann JM, Borrensen-Dale AL, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholom N, Tretli S, Yuen J, Boice Jr JD, Tucker M (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 93: 121-127
17. Pause FG, Wacker P, Maillet P, Betts D, Sappino A-P (2003) ATM gene alterations in childhood acute lymphoblastic leukemias. Hum Mut 21: 554
18. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Sankhavaram R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y (1995a) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
19. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G (1995b) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4: 2025-2032
20. Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 97: 2773-2778
21. Schaffner C, Stilgenbauer S, Rappold GA, Dohner H, Lichter P (1999) Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94: 748-753
22. Scott SP, Bendix R, Chen P, Clark R, Dork T, Lavin MF (2002) Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc Natl Acad Sci USA 99: 925-930
23. Shiloh Y (1995) Ataxia-telangiectasia. Close to unraveling the mystery. Eur J Hum Genet 3: 116-138
24. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155-168
25. Stankovic T, Stewart GS, Fegan C, Biggs P, Last J, Byrd PJ, Keenan RD, Moss PA, Taylor AM (2002) Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood 99: 300-309
26. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PAH, Taylor AMR (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia. Lancet 353: 26-29
27. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Dohner H (1997) Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3: 1155-1159
28. Stilgenbauer S, Winkler D, Ott G, Schaffner C, Leupolt E, Bentz M, Moller P, Muller-Hermelink HK, James MR, Lichter P, Dohner H (1999) Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 94: 3262-3264
29. Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F, Stern M-H (1998) Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91: 3920-3926
30. Su Y, Swift M (2000) Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133: 770-778
31. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia telangiectasia. N Engl J Med 325: 1831-1836
32. Taylor AMR, Metcalfe JA, Thick J, Mak Y-F (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87: 423-438
33. Thorstenson YR, Shen P, Tusher VG, Wayne TL, Davis RW, Chu G, Oefher PJ (2001) Global analysis of ATM polymorphism reveals significant functional constraint. Am J Hum Genet 69: 396-412
34. Tilly H, Bastard C, Delastre T, Duval CM, Bizet M, Lenormand B, Dauce J-P, Monconduit M, Piguet H (1991) Cytogenetic studies in untreated Hodgkin disease. Blood 77: 1298-1304
35. Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster ADB, Yuille MAR (1997) Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17: 96-99
36. Yuille MA, Coignet LJ, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovsky I, Dyer MJ, Catovsky D (1998) ATM is usually rearranged in T-cell prolymphocytic leukemias. Oncogene 16: 789-796